Atlas FDA

VNS THERAPY SYSTEM

FDA premarket approval P970003/S140 · decided 2011-12-20

Approval details

PMA number
P970003
Supplement
S140
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
VNS THERAPY SYSTEM
Generic name
Stimulator, autonomic nerve, implanted for epilepsy
Applicant
LivaNova USA, Inc.
Date received
2011-10-21
Decision date
2011-12-20
Days to decision
60 days
Decision code
APPR
Product code
LYJ
Advisory committee
Neurology
Expedited review
No
Location
Houston, TX
Statement
APPROVAL FOR : 1) REMOVAL OF THE CR10 AND CR11 TVS DIODES FROM THE PCBA DESIGN; AND 2) A CHANGE TO THE PRINTED CIRCUIT BOARD (PCB) SPECIFICATION TO ACCEPT VIAS (VERTICAL ELECTRICAL CONNECTIONS BETWEEN DIFFERENT LAYERS OF CONDUCTORS ON A PCB) FILLED WITH EPOXY FROM THE PCB VENDOR, WHICH IS CURRENTLY ALLOWED FOR THE MODEL 103/104 PULSE GENERATORS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Venous Return Cannulae (K250937)LivaNova USA, Inc.2026-03-11
RAP Femoral Venous Cannulae (K250283)LivaNova USA, Inc.2025-07-10
SMARxT Tubing and Connectors (K233702)LivaNova USA, Inc.2024-08-08